HealthEquity Inc (HQY)
79.84
+0.38
(+0.48%)
USD |
NASDAQ |
May 23, 16:00
81.53
+1.69
(+2.12%)
Pre-Market: 08:09
HealthEquity SG&A Expense (Quarterly): 45.85M for Jan. 31, 2024
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
January 31, 2024 | 45.85M |
October 31, 2023 | 46.04M |
July 31, 2023 | 46.21M |
April 30, 2023 | 44.83M |
January 31, 2023 | 41.88M |
October 31, 2022 | 42.38M |
July 31, 2022 | 41.78M |
April 30, 2022 | 40.29M |
January 31, 2022 | 38.25M |
October 31, 2021 | 32.73M |
July 31, 2021 | 38.29M |
April 30, 2021 | 34.77M |
January 31, 2021 | 36.36M |
October 31, 2020 | 34.98M |
July 31, 2020 | 32.66M |
April 30, 2020 | 30.45M |
January 31, 2020 | 37.30M |
October 31, 2019 | 31.88M |
July 31, 2019 | 17.65M |
April 30, 2019 | 17.68M |
January 31, 2019 | 16.37M |
October 31, 2018 | 16.66M |
Date | Value |
---|---|
July 31, 2018 | 15.14M |
April 30, 2018 | 14.37M |
January 31, 2018 | 14.19M |
October 31, 2017 | 12.14M |
July 31, 2017 | 11.43M |
April 30, 2017 | 10.49M |
January 31, 2017 | 10.42M |
October 31, 2016 | 9.557M |
July 31, 2016 | 9.74M |
April 30, 2016 | 8.757M |
January 31, 2016 | 8.20M |
October 31, 2015 | 6.544M |
July 31, 2015 | 6.68M |
April 30, 2015 | 5.991M |
January 31, 2015 | 6.881M |
October 31, 2014 | 4.718M |
July 31, 2014 | 3.987M |
April 30, 2014 | 3.376M |
January 31, 2014 | 4.412M |
October 31, 2013 | 2.77M |
July 31, 2013 | 2.662M |
April 30, 2013 | 2.655M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
17.65M
Minimum
Jul 2019
46.21M
Maximum
Jul 2023
37.61M
Average
38.25M
Median
Jan 2022
SG&A Expense (Quarterly) Benchmarks
Cardinal Health Inc | 1.282B |
Cyclacel Pharmaceuticals Inc | 1.582M |
Elevance Health Inc | -- |
Precigen Inc | 10.15M |
Corvus Pharmaceuticals Inc | 2.178M |